Astellas Pharma, Inc. (ALPMY)
15.04
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Astellas Pharma Profit Margin (Quarterly) : 22.12% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.12% |
| March 31, 2026 | 8.11% |
| December 31, 2025 | 17.56% |
| September 30, 2025 | 15.11% |
| June 30, 2025 | 13.53% |
| March 31, 2025 | 16.31% |
| December 31, 2024 | -18.87% |
| September 30, 2024 | 7.76% |
| June 30, 2024 | 7.95% |
| March 31, 2024 | -8.03% |
| December 31, 2023 | 3.44% |
| September 30, 2023 | -0.37% |
| June 30, 2023 | 8.83% |
| March 31, 2023 | -13.02% |
| December 31, 2022 | 12.04% |
| September 30, 2022 | 18.83% |
| June 30, 2022 | 6.50% |
| March 31, 2022 | -2.77% |
| December 31, 2021 | 17.87% |
| September 30, 2021 | 12.57% |
| June 30, 2021 | 9.41% |
| March 31, 2021 | -3.99% |
| December 31, 2020 | 18.46% |
| September 30, 2020 | 7.27% |
| June 30, 2020 | 16.42% |
| Date | Value |
|---|---|
| March 31, 2020 | 1.73% |
| December 31, 2019 | 18.19% |
| September 30, 2019 | 22.13% |
| June 30, 2019 | 17.51% |
| March 31, 2019 | 10.20% |
| December 31, 2018 | 24.49% |
| September 30, 2018 | 15.50% |
| June 30, 2018 | 16.58% |
| March 31, 2018 | 7.33% |
| December 31, 2017 | 16.82% |
| September 30, 2017 | 12.50% |
| June 30, 2017 | 13.17% |
| March 31, 2017 | 13.04% |
| December 31, 2016 | 18.01% |
| September 30, 2016 | 15.43% |
| June 30, 2016 | 19.72% |
| March 31, 2016 | 9.49% |
| December 31, 2015 | 16.29% |
| September 30, 2015 | 16.96% |
| June 30, 2015 | 12.98% |
| March 31, 2015 | 7.17% |
| December 31, 2014 | 12.49% |
| September 30, 2014 | 11.40% |
| June 30, 2014 | 12.15% |
| December 31, 2013 | 10.06% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 11.94% |
| Takeda Pharmaceutical Co., Ltd. | 9.28% |
| Ono Pharmaceutical Co., Ltd. | 20.80% |
| Eisai Co., Ltd. | 8.17% |
| Chugai Pharmaceutical Co., Ltd. | 34.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.07% |
| Return on Assets | 10.28% |
| Return on Invested Capital | 14.81% |
| Gross Profit Margin (Quarterly) | 75.29% |
| Operating Margin (Quarterly) | 28.98% |
| Return on Net Operating Assets | 12.63% |